Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05218980 · ClinicalTrials.gov registry record · NA

Health-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For Health

A NA study, sponsored by Yale University.

Not yet
Registry status
NA
Development phase
226
Enrollment target

NCT05218980: Clinical Trial NA study, sponsored by Yale University.

NCT05218980 is a NA study that has not yet begun recruiting, run by Yale University. The registered enrollment target is 226 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05218980, a NA study, has not yet begun recruiting, sponsored by Yale University.

NOT YET RECRUITING
Registry status
NA
Development phase
226 participants
Enrollment target

Study Summary

The purpose of this study is to assess whether introducing table olives into the diet results in health-related benefits for young adults. Several studies have shown that addition of olives as part of somebody's diet has a positive impact on cardiovascular, metabolic, and inflammatory factors. However, there have not been many studies among young, healthy adults. This study will compare levels of specific biomarkers, collected through blood draw, at the beginning of the study and after 5 weeks, to evaluate the effects of investigational daily olive consumption.

Primary Outcome

Blood draw to assess LDL at baseline and week five. Change will be calculated by comparing means of the differences (5 weeks-Baseline) between the two study groups, a decrease in the mean from baseline is positive.

Interventions

  • DIETARY_SUPPLEMENT Olives

Trial Details

FieldValue
Enrollment Target 226 participants
Start Date 2027-01
Est. Completion 2027-06
Phase NA
Yale University

1,492 total trials

What is known before NCT05218980 opens enrollment

NCT05218980 is an interventional study that assigns participants to a tested intervention. The registered 226 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 1 intervention - of which Olives is the first listed.

NCT05218980 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05218980 about?

NCT05218980 is a clinical study titled "Health-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For Health". The purpose of this study is to assess whether introducing table olives into the diet results in health-related benefits for young adults. Several studies have shown that addition of olives as part of somebody's diet has a positive impact on cardiovascular, metabolic, and inflammatory factors. Howev...

What is the current status of trial NCT05218980?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 226 participants. The study started on 2027-01. Estimated completion is 2027-06.

What interventions are being tested in trial NCT05218980?

The interventions under investigation include: Olives (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05218980?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05218980's enrollment target sits among peer trials

226 471st of 2000 higher than 1,529 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04419272 · 226 participants · Phase 4

    Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

  • NCT05449002 · 226 participants · NA

    Digital Single Session Intervention for Youth Mental Health

  • NCT05488054 · 226 participants · NA

    Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery

  • NCT05924477 · 226 participants · NA

    Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT05218980, the US trial registry maintained by the National Library of Medicine. NCT05218980 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.